The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Comprehensive Geriatric Assessment and Management for Canadian Elders With Cancer
Official Title: Clinical and Cost-effectiveness of a Comprehensive Geriatric Assessment and Management for Canadian Elders With Cancer: the 5C Study
Study ID: NCT03154671
Brief Summary: A multicentre two-group parallel single-blind (outcome assessor) randomized controlled trial (RCT). A cost effectiveness study alongside a clinical trial using a payer and societal perspective to study the cost-effectiveness of geriatric assessment and management compared to usual care will be conducted. Participants allocated to the control group will receive usual oncology care. Participants allocated to the intervention group will receive a comprehensive geriatric assessment and management in addition to their usual oncology care. The intervention will take 6 months to be completed. Total study follow-up will be 12 months for each participant.
Detailed Description:
Minimum Age: 70 Years
Eligible Ages: OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Lakeridge Health, Oshawa, Ontario, Canada
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Name: Martine Puts, RN PhD
Affiliation: University of Toronto
Role: PRINCIPAL_INVESTIGATOR